(Journal Article): Approaches Towards Endogenous Pancreatic Regeneration
 
Banerjee M, Kanitkar M, Bhonde RR (Tissue Engineering and Banking Laboratory, National Centre for Cell Science, Ganeshkhind, Pune-411007, rrbhonde(at)nccs.res.in )
 
IN: Rev Diabetic Stud 2005; 2(3):165-176
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

Fulltext:    HTML  PDF

ABSTRACT: The phenomenon of pancreatic regeneration in mammals has been well documented. It has been shown that pancreatic tissue is able to regenerate in several species of mammal after surgical insult. This tissue is also known to have the potential to maintain or increase its β-cell mass in response to metabolic demands during pregnancy and obesity. Since deficiency in β-cell mass is the hallmark of most forms of diabetes, it is worthwhile understanding pancreatic regeneration in the context of this disease. With this view in mind, this article aims to discuss the potential use in clinical strategies of knowledge that we obtained from studies carried out in animal models of diabetes. Approaches to achieve this goal involve the use of biomolecules, adult stem cells and gene therapy. Various molecules, such as glucagon-like peptide-1, β-cellulin, nicotinamide, gastrin, epidermal growth factor-1 and thyroid hormone, play major roles in the initiation of endogenous islet regeneration in diabetes. The most accepted hypothesis is that these molecules stimulate islet precursor cells to undergo neogenesis or to induce replication of existing β-cells, emphasizing the importance of pancreas-resident stem/progenitor cells in islet regeneration. Moreover, the potential of adult stem cell population from bone marrow, umbilical cord blood, liver, spleen, or amniotic membrane, is also discussed with regard to their potential to induce pancreatic regeneration.

TYPE OF PUBLICATION: Review

REFERENCES:

1. Bouckenooghe T, Vandewalle B, Moerman E, Danze PM, Lukowiak B, Muharram G, Kerr-Conte J, Gmyr V, Laine B, Pattou F. Expression of progenitor cell markers during expansion of sorted human pancreatic beta-cells. Gene Expr 2005. 12: 83-98.
2. Silver K, Tolea M, Wang J, Pollin TI, Yao F, Mitchell BD. The Exon1 Cys7Gly polymorphism within the Betcellulin gene is associated with Type2 Diabetes in African Americans. Diabetes 2005. 54:1179-1184.
3. Huotari MA, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinol 1998. 139:1494-1499.
4. Lei L, Zhaohong Y, Mashaharu S, Kojima I. Activin A and Betacellulin: Effect on regeneration of pancreatic beta-cells in neonatal streptozotocin- treated rats. Diabetes 2004. 53:608-615.
5. Li L, Seno M, Yamada H, Kojima I. Betacellulin improves glucose metabolism by promoting conversion of intra-islet precursor cells to beta-cells in streptozotocin-treated mice. American Journal of Physiology Endocrinology and Metabolism 2003. 285:577-583.
6. Yoshikumi Y, Mashima H, Udea N, Ohno H, Suzuki J, Tanaka S, Hayashi M, Sekine N, Ohnishi H, Yasuda H, Iiri T, Omata M, Fujita T, Kojima I. Roles of CTPL/Sfxn3 family members in pancreatic islet. Journal of Cellular Biochemistry 2005. 95:1157-1168.
7. Bolkent S, Yanardag R, Tabakoglu-Oguz A, Ozsoy-Sacan O. Effects of Chard extract (Beta vilgaris L.var.Cicla) extract on pancreatic beta-cells in streptozotocin –diabetic rats: a morphological and biochemical study. J Ethanopharmacol 2000. 73:251-259.
8. Xiu LM, Miura AB, Yamamoto K, Kobayashi T, Song QH, Kitamura H, Cyong JC. Pancreatic islet regeneration by ephedrine in mice with streptozotocin-induced diabetes. Am J Chin Med 2001. 29:493-500.
9. Vague P, Picq R, Bernal M, Lassmann-Vague V, Vialettes B. Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin dependant) diabetic patients. Diabetologia 1989. 32:316-321.
10. Fernandez-Alvarez J, Barbera A, Nadal B, Barcelo-Batllori S, Piquer S, Claret M, Guinovart JJ, Gomis R. Stable and functional regeneration of pancreatic beta-cell population in STZ-rats treated with tungstate. Diabetologia 2004. 47:470-477.
11. Kim BM, Han YM, Shin YJ, Min BH, Park IS. Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats. Diabetologia 2001. 44:2192-2202.
12. Kato K, Isaji S, Kawarada Y, Hibasami H, Nakashima K. Effect of zinc administration on pancreatic regeneration after 80% pancreatectomy. Pancreas 1997. 14:158-165.
13. Taylor CG. Zinc, the pancreas, and diabetes: insight from rodent studies and future directions. Biomaterial 2005. 18:305-312.
14. Majumdar AP, Vesenka GD, Dubick MA. Acceleration of pancreatic regeneration by cholecytokinin in rats. Pancreas 1978. 2:199-204.
15. Morriset J. Intervention of GI neuropeptides in pancreatic growth and regeneration: a comparison with cholecytokinin. Journal of Physio. Pharmacol 2003. 54:127-141.
16. Fiorucci S, Bufalari A, Distrutti E, Lanfrancone L, Servoli A, Sarpi L, Federici B, Bartoli A, Morelli A, Moggi L. Bombesin-induced pancreatic regeneration in pigs is mediated by p46Shc/p52Shc and p42/p44 mitogen-activated protein kinase upregulation. Scand J Gastroenterol 1998. 33:1310-1320.
17. Ledda-Columbano GM, Perra A, Pibiri M, Molotzu F, Columbano A. Induction of pancreatic acinar cell proliferation by thyroid hormone. Journal of Endocrinology 2005. 185:393-399.
18. Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K, Yan Y. Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 2002. 91:414-420.
19. Hayashi KY, Tamaki H, Hand K, Takahashi T, Kakita A, Yamashina S. Differentiation and proliferation of endocrine cells in the regenerating rat pancreas after 90% pancreatectomy. Arch Histol Cytol 2003. 66:163-174.
20. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999. 48:2270-2276.
21. De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA, Roleo F. Endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 2003. 52:365-371.
22. Jetton TL, Liu YQ, Trotman WE, Nevin PW, Sun XJ, Leahy JL. Enhanced expression of insulin receptor substrate-2 and activation of protein kinase B/Akt in regenerating pancreatic duct epithelium of 60%-partial pancreatectomy rats. Diabetologia 2001. 44:2056-2065.
23. Smith FE, Rosen KM, Villa-Komaroff L, Weir GC, Bonner-Weir S. Enhanced insulin-like growth actor-I gene expression in regenerating rat pancreas. Proc Natl Acad Sci. USA 1991. 88:6152-6156.
24. Li L, Seno M, Yamada H, Kojima I. Promotion of beta-cell regeneration by betacellulin in 90% pancreatectomized rats. Endocrinology 2001. 142:5279-5385.
25. Yonemura Y, Takashima T, Miwa K, Miyazaki I, Yamamoto H, Okamoto H. Amelioration of diabetes mellitus in partially pancreatectomized rats by poly (ADP-ribose) synthase inhibitors. Evidence of islet beta-cell regeneration. Diabetes 1984. 33:401-404.
26. Sugiyama K, Yonemura Y, Okamoto H. Effects of poly (ADP-ribose) synthase inhibitors on B-cells of a canine pancreas after massive pancreatectomy. Pancreatol 1991. 8:85-95.
27. Gross DJ, Weiss L, Reibstein I, Van den Brand J, Okamoto H, Clark A, Slavin S. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with reg protein treatment. Endocrinol 1998. 139:2369-2374.
28. De Breuck S, Lardon J, Rooman I, Bouwens L. Netrin-expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells. Diabetologia 2003. 46:926-933.
29. Rosenberg L. Induction of islet cell neogenesis in the adult pancreas: the partial duct obstruction model. Microsc Res Tech. 1998. 43:337-346.
30. Hardikar AA, Karandikar MS, Bhonde RR. Effect of partial pancreatectomy on diabetic status in BALB/c mice. J Endocrinol. 1999. 162:185-195.
31. Hardikar AA, Bhonde RR. Modulating experimental diabetes by treatment with cytosolic extract from the regenerating pancreas. Diabetes Res and Clin Pract. 1999. 46:203-211.
32. Kanitkar M, Bhonde R. Existence of islet regenerating factors within the pancreas. Rev Diabetic Stud. 2004. 1:185-192.
33. Swenne I, Andersson A. Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 1984. 27:464-467.
34. Asanuma N, Kitamura T, Xu X, Sumitani S, Saito H, Kasayama S, Kouhara H, Kawase I. New analytical method for pancreas and liver regeneration: normalization of streptozotocin-induced hyperglycemia by retrograde injection of insulin producing cells. Endocr J 2002. 49:449-457.
35. Yamamoto M, Yasuda M, Hori A, Arishima K, Eguchi Y. Recovery in the fetal pancreatic islet following fetal administration of streptozotocin in the rat in vivo and in vitro. Anat Rec A Discov Mol Cell Evol Biol 2004. 281:1319-1325.
36. Guz Y, Nasir I, Teitelman G. Regeneration of pancreatic beta-cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 2001. 142:4956-4968.
37. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004. 429:41-46.
38. Seaberg RM, Smukler SR, Kieffer TJ, Enikolopov G, Asghar Z, Wheeler MB, Korbutt G, van der Kooy D. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004. 22:1115-1124.
39. Bouwens L, Blay ED. Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem 1996. 44:947-951.
40. Bouwens L, Lu WG, Krijger RD. Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 1997. 40:398-404.
41. Bertelli E, Regoli M, Orazioli D, Bendayan M. Association between islets of Langerhans and pancreatic ductal system in adult rat. Where endocrine and exocrine meet together? Diabetologia 2001. 44:575-84.
42. Bouwens L, Pipeleers DG. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 1998. 41:629-633.
43. Dudek RW, Lawrence IE Jr, Hill RS, Johnson RC. Induction of islet cytodifferentiation by fetal mesenchyme in adult pancreatic ductal epithelium. Diabetes 1991. 40:1041-1048.
44. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O'Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A 2000. 97:7999-8004.
45. Elkin G, Prigozhina TB, Slavin S. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol 2004. 32:579-584.
46. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003. 21:763-770.
47. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003. 111:843-850.
48. Scheffold YC, Weissman IL, Taylor C, Jerabek L, Burge MJ, Masek MA, Shizuru JA. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 2003. 52:59-68.
49. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL, Habener JF. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004. 53:616-623.
50. Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, Mochizuki H, Migita M, Shimada T, Kawamori R, Watada H. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta-cells. Diabetologia 2003. 46:1366-1374.
51. Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Gambrell B, Bottino R, Styche AJ, Trucco M. Recovery of the endogenous beta-cell function in the NOD model of autoimmune diabetes. Stem Cells 2003. 21:377-388.
52. Beilhack GK, Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004. 53:91-98.
53. Banerjee M, Kumar A, Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 2005. 328:318-325.
54. Izumida Y, Aoki T, Yasuda D, Koizumi T, Suganuma C, Saito K, Murai N, Simizu Y, Hayashi K, Odaira M, Kusano T, Kushima M, Kusano M. Hepatocyte growth factor is constitutively produced by donor derived bone marrow cells and promotes regeneration of pancreatic beta-cells. Biochem Biophys Res Commun 2005. 333:273-282.
55. Grompe M. Pancreatic-hepatic switches in vivo. Mech Dev 2003. 120:99-106.
56. Zheng YW, Taniguchi H. Diversity of hepatic stem cells in the fetal and adult liver. Semin Liver Dis 2003. 23:337-348.
57. Kojima H, Nakamura T, Fujita Y, Kishi A, Fujimiya M, Yamada S, Kudo M, Nishio Y, Maegawa H, Haneda M, et al. Combined expression of pancreatic duodenal box 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 51:1398-1408.
58. Fujita Y, Cheung AT, Kieffer TJ. Harnessing the gut to treat diabetes. Pediatr Diabetes 2004. 5 Suppl:57-69.
59. Bjerknes M, Cheng H. Gastrointestinal Stem Cells. II. Intestinal stem cells. Am J Physiol Gastrointest Liver Physiol 2005. 289:381-387.
60. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003. 302:1223-1227.
61. Kodama S, Davis M, Faustman DL. Diabetes and stem cell researchers turn to the lowly spleen. Sci Aging Knowledge Environ 2005. 19:2.
62. Krapp A, Knofler M, Ledermann B, Burki K, Berney C, Zoerkler N, Hagenbuchle O, Wellauer PK. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev 1998. 12:3752-3763.
63. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004. 325:665-669.
64. Ende N, Chen R, Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun 2004. 321:168-171.
65. Naruse K, Hamada Y, Nakashima E, Kato K, Mizubayashi R, Kamiya H, Yuzawa Y, Matsuo S, Murohara T, Matsubara T, Oiso Y, Nakamura J. Cord blood stem cells: Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005. 54:1823-1828.
66. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T, Kato K, Konishi I, Nikaido T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant 2003. 12:545-552.
67. Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M. Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of β-cell function in overtly diabetic nonobese diabetic mice. Transplantation 2005. 79:1091-1096.
68. Zhang YQ, Cleary MM, Si Y, Liu G, Eto Y, Kritzik M, Dabernat S, Kayali AG, Sarvetnick N. Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic beta-cells. Diabetes 2004. 53:2024-2033.
69. Tian C, Bagley J, Cretin N, Seth N, Wucherpfennig KW, Iacomini J. Prevention of type 1 diabetes by gene therapy. J Clin Invest 2004. 114:969-978.
70. Morral N. Gene therapy for type 1 diabetes. New approaches. Minerva Med 2004. 95:93-104.
71. Suzuki A, Nakauchi H, Taniguchi H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 2004. 53:2143-2152.
72. Petropavlovskaia M, Rosenberg L. Identification and characterization of small cells in the adult pancreas: potential progenitor cells? Cell Tissue Res 2002. 310:51-58.